Personalized Treatment for Serious Mental Illness
Treatments studied
Part of Mental health clinical trials.
This study tests whether combining medicine adjustments, lifestyle changes (like diet and exercise), and optional brain stimulation can help people with schizophrenia, bipolar disorder, or depression feel better and function more independently. It may include a weight-loss medication if you're overweight or obese.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18–65 years old
- Diagnosed with schizophrenia, bipolar disorder, or major depression (confirmed by a clinical interview)
- Mental illness symptoms are stable on your current medication for at least 2 weeks
- Your quality of life is reduced (not functioning as well as you'd like)
- No serious thoughts of suicide right now
- No active drug or alcohol dependence in the past 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a program to improve heart health in people with schizophrenia or bipolar disorder who take antipsychotic medication or lithium and have a high body weight. The goal is to help reduce heart disease risk.
This study is developing more personalized treatments for schizophrenia, depression, or bipolar disorder. It may help find the best treatment approach for your specific situation.
This study tests whether a small electrical stimulation device targeting a specific brain region (the suprachiasmatic nucleus) can help improve metabolic health and weight in people with stable bipolar disorder who also have obesity. The goal is to see if this approach is safe and effective.
This study wants to see if a personalized approach with FDA-approved weight-loss medications can help people with bipolar disorder who are overweight or have obesity, while staying on their mood stabilizer treatment. It might be a good fit if you have bipolar disorder and struggle with your weight.
This study tests whether a medication that helps with weight loss, called a GLP-1 agonist, can also change how the brain works. It is for teenagers (12-18) and adults (30-45) with obesity.
This study tests whether a weekly injection of semaglutide (a medication used for weight loss and diabetes) can help reduce symptoms of depression in people who have major depressive disorder and are overweight or obese.
Hear when a new Severe Mental Illness trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.